华仁药业 (300110.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(华仁药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 406,703,155.731,636,256,356.791,215,927,751.99829,046,309.50403,241,817.911,619,492,335.021,104,386,605.27721,957,803.22385,486,122.57
 营业利润(元) 58,680,286.50225,944,323.30154,749,072.0488,435,618.6846,679,557.32198,490,746.68144,884,723.6792,854,078.0733,107,663.54
 利润总额(元) 57,699,011.68230,514,670.04157,214,089.0790,717,752.6646,751,754.94205,859,090.86151,568,503.2690,065,431.1032,435,058.22
 净利润(元) 52,378,184.34193,424,735.15140,650,990.5184,438,182.9941,870,660.50181,337,643.24126,274,142.8276,033,080.9526,181,499.72
 归属于母公司股东的净利润(元) 50,822,916.88188,063,014.38137,083,571.5982,281,868.8941,102,886.41180,815,847.76123,211,073.7774,101,286.6725,039,647.36
盈利能力:
 销售毛利率(%) 42.0442.7243.8442.1741.6743.2744.5545.3049.13
 销售净利率(%) 12.8811.8211.5710.1910.3811.2011.4310.536.79
 净资产收益率(%) 1.917.205.363.281.65----
 总资产报酬率ROA(%) 1.455.694.052.351.17----
 投入资本回报率ROIC(%) 1.134.173.031.790.924.082.801.650.57
营运能力:
 存货周转率(次) 0.843.122.131.680.94----
 应收账款周转率(次) 0.612.531.721.140.54----
 总资产周转率(次) 0.080.320.240.160.08----
偿债能力:
 资产负债率(%) 43.6546.4647.5450.0348.5949.6450.1753.0053.78
 股东权益比率(%) 54.8852.1551.1148.6850.0649.0248.3645.6044.85
 已获利息倍数(倍) 4.604.644.093.654.164.144.043.722.95
 流动比率 1.721.841.611.501.521.341.321.281.32
 速动比率 1.481.581.351.291.331.181.111.091.14
发展能力:
 营业收入增长率(%) 0.861.0410.1014.834.613.76-2.472.7312.27
 营业利润增长率(%) 25.7113.836.81-4.7640.9931.19-3.326.460.06
 税后利润增长率(%) 23.654.0311.2611.0464.1538.665.050.810.86
 净资产增长率(%) 6.726.456.876.777.336.734.884.744.94
 总资产增长率(%) -2.660.061.120.02-3.83-8.49-11.5515.8830.51

前瞻产业研究院